Imfinzi Recommended for EU Approval as First Immunotherapy for Limited-Stage Small Cell Lung Cancer Read more
Sarclisa Approved in China as First Anti-CD38 Treatment for Newly Diagnosed Multiple Myeloma Read more
FDA Grants Priority Review to Merck’s WELIREG for Advanced Pheochromocytoma and Paraganglioma Read more
Pfizer’s BRAFTOVI Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer Read more
AbbVie and Neomorph Partner to Develop Molecular Glue Degraders for Oncology and Immunology Read more
FDA Approves SPRAVATO (esketamine) as First and Only Monotherapy for Treatment-Resistant Depression in Adults Read more